Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy

  • Technology appraisal guidance
  • TA307
  • Published: 
Download guidance (PDF)

6 Review of guidance

6.1 The guidance on this technology will be considered for review in August 2016. The Guidance Executive will decide whether the technology should be reviewed based on information gathered by NICE, and in consultation with consultees and commentators.

Andrew Dillon
Chief Executive
March 2014